Researchers are utilizing a turbocharged version of the CRISPR technology to gain insight into the immune system's fight against cancer. The work is associated with Harvard Medical School, where it is viewed as part of a broader effort that may also involve bacterial design. The project's goals and methods are being explored as a new area of investigation.